D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Walt Disney
DIS
|
+$410M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
GE Aerospace
GE
|
+$196M |
| 5 |
Dell
DELL
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$374M |
| 2 |
PayPal
PYPL
|
+$289M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Nike
NKE
|
+$227M |
| 5 |
Amgen
AMGN
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Brinker International
EAT
$8.38B
| $1.27M | ﹤0.01% |
25,278
-250,046
| -91% | -$12.6M |
|
|
PBPB
2202
DELISTED
Potbelly
PBPB
| $1.27M | ﹤0.01% |
102,457
+56
| +0.1% | +$725 |
|
2203
CALL
Acadia Pharmaceuticals
ACAD
$4.35B
| $1.27M | ﹤0.01% |
40,000
| – | – |
|
2204
PUT
DXP Enterprises
DXPE
$2.57B
| $1.27M | ﹤0.01% |
45,000
-21,100
| -32% | -$486K |
|
2205
PUT
3M
MMM
$91.9B
| $1.27M | ﹤0.01% |
8,611
+6,697
| +350% | +$1,000K |
|
2206
Pacific Biosciences
PACB
$422M
| $1.27M | ﹤0.01% |
141,568
-75,316
| -35% | -$630K |
|
2207
Qorvo
QRVO
$7.92B
| $1.27M | ﹤0.01% |
+22,774
| New | +$1.29M |
|
2208
First Solar
FSLR
$22.1B
| $1.27M | ﹤0.01% |
32,105
+15,660
| +95% | +$649K |
|
2209
AngioDynamics
ANGO
$565M
| $1.26M | ﹤0.01% |
71,994
-35,988
| -33% | -$584K |
|
|
AYR
2210
DELISTED
Aircastle Ltd
AYR
| $1.26M | ﹤0.01% |
+63,562
| New | +$1.33M |
|
|
SCMP
2211
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.26M | ﹤0.01% |
102,501
+75,854
| +285% | +$894K |
|
|
HES
2212
DELISTED
Hess
HES
| $1.26M | ﹤0.01% |
23,458
-43,070
| -65% | -$2.31M |
|
2213
Ionis Pharmaceuticals
IONS
$9.25B
| $1.26M | ﹤0.01% |
34,270
-8,346
| -20% | -$261K |
|
2214
Sumitomo Mitsui Financial
SMFG
$167B
| $1.26M | ﹤0.01% |
186,063
-241,627
| -56% | -$1.57M |
|
|
SNOW
2215
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $1.26M | ﹤0.01% |
77,453
+24,966
| +48% | +$380K |
|
2216
PUT
Elevance Health
ELV
$82.1B
| $1.25M | ﹤0.01% |
10,000
| – | – |
|
|
SF
2217
PUT
Stifel
SF
$12.5B
| $1.25M | ﹤0.01% |
73,125
| – | – |
|
2218
Olin
OLN
$2.49B
| $1.25M | ﹤0.01% |
60,862
+31,862
| +110% | +$686K |
|
|
CALD
2219
DELISTED
Callidus Software, Inc.
CALD
| $1.25M | ﹤0.01% |
68,009
+1,312
| +2% | +$25.6K |
|
2220
PUT
Fair Isaac
FICO
$29.7B
| $1.25M | ﹤0.01% |
+10,000
| New | +$1.25M |
|
2221
MYR Group
MYRG
$5.75B
| $1.25M | ﹤0.01% |
41,382
+7,146
| +21% | +$196K |
|
|
TTSH
2222
DELISTED
Tile Shop Holdings
TTSH
| $1.25M | ﹤0.01% |
75,220
-76,240
| -50% | -$1.31M |
|
|
CBPO
2223
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.25M | ﹤0.01% |
10,000
-10,900
| -52% | -$1.29M |
|
2224
PUT
SM Energy
SM
$7.26B
| $1.24M | ﹤0.01% |
32,200
| – | – |
|
2225
Larimar Therapeutics
LRMR
$398M
| $1.24M | ﹤0.01% |
31,190
-3,835
| -11% | -$174K |
|
Similar funds
D.E. Shaw & Co's Q3 2016 Portfolio in Review
As of Q3 2016, D.E. Shaw & Co held 3,773 positions worth $56.7B, up 4.5% from $54.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2016 filing shows 448 new, 1,212 increased, 1,374 reduced and 429 closed positions. Its largest new stake was Dell: 13,808,231 shares worth $185M. The largest sale was Meta Platforms (Facebook), an estimated $374M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
- D.E. Shaw & Co's largest Q3 2016 buy was Dell: 13,808,231 shares worth $185M.
- D.E. Shaw & Co added most to Apple in Q3 2016, an estimated $453M increase.
- D.E. Shaw & Co's biggest Q3 2016 reduction was Meta Platforms (Facebook), cutting an estimated $374M.
- D.E. Shaw & Co fully exited EMC CORPORATION in Q3 2016, selling an estimated $278M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $56.7B portfolio in Q3 2016.
- D.E. Shaw & Co opened 448 new positions and closed 429 in Q3 2016.
- D.E. Shaw & Co's portfolio value rose 4.5% quarter-over-quarter to $56.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.